Irofulven hydroxymethylacylfulvene: MOGN started an international Phase I trial of irofulven plus capecitabine in 40 patients with advanced solid tumors

MGI Pharma Inc. (MOGN), Minneapolis, Minn.

Read the full 67 word article

How to gain access

Continue reading with a
two-week free trial.